Analysis of protein phosphorylation and cellular signaling events by flow cytometry: Techniques and clinical applications

Clinical Immunology

Volumn 110, Issue 3, 2004, Pages 206-221

  Krutzik, Peter O ^a   Irish, Jonathan M ^a   Nolan, Garry P ^a   Perez, Omar D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Disease characterization; Drug screening; Intracellular; Multiparameter; Phospho specific antibodies; Phosphorylation

Indexed keywords

ANTIBODY; ANTIGEN; EPITOPE;

ANTIGEN SPECIFICITY; BIOINFORMATICS; CELL PERMEABILIZATION; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; REVIEW; STAINING;

EID: 1642463417     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.11.009     Document Type: Article

References (78)

1. De Rosa S.C., Herzenberg L.A., Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7:2001;245-248.
2. De Rosa S.C., Roederer M. Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. Clin. Lab. Med. 21:2001;697-712. (vii).
3. Marodi L., Goda K., Palicz A., Szabo G. Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma. Clin. Exp. Immunol. 126:2001;456-460.
4. Pala P., Hussell T., Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods. 243:2000;107-124.
5. Schmitz J., Assenmacher M., Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23:1993;191-199.
6. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods. 159:1993;197-207.
7. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1995;1357-1367.
8. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
9. McCubrey J.A., May W.S., Duronio V., Mufson A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia. 14:2000;9-21.
10. Cobb M.H., Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
11. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
12. Adams J.A. Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model? Biochemistry. 42:2003;601-607.
13. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
14. O'Shea J.J., Gadina M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109:2002;S121-S131. (Suppl.).
15. Aaronson D.S., Horvath C.M. A road map for those who know JAK-STAT. Science. 296:2002;1653-1655.
16. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 285:2002;1-24.
17. Singer A.L., Koretzky G.A. Control of T cell function by positive and negative regulators. Science. 296:2002;1639-1640.
18. Fiering S., Northrop J.P., Nolan G.P., Mattila P.S., Crabtree G.R., Herzenberg L.A. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev. 4:1990;1823-1834.
19. Ferrell J.E. Jr., Machleder E.M. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science. 280:1998;895-898.
20. Ferrell J.E. Jr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14:2002;140-148.
21. Drevs J., Medinger M., Schmidt-Gersbach C., Weber R., Unger C. Receptor tyrosine kinases: the main targets for new anticancer therapy. Curr. Drug Targets. 4:2003;113-121.
22. Lohrisch C., Piccart M. HER2/neu as a predictive factor in breast cancer. Clin. Breast Cancer. 2:2001;129-135. (discussion 136-7).
23. Chow S., Patel H., Hedley D.W. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 46:2001;72-78.
24. Krutzik P.O., Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry. 55A:2003;61-70.
25. Petit J.M., Denis-Gay M., Ratinaud M.H. Assessment of fluorochromes for cellular structure and function studies by flow cytometry. Biol. Cell. 78:1993;1-13.
26. Mullins J.M. Overview of fluorophores. Methods Mol. Biol. 34:1994;107-116.
27. Shapiro H.M. Optical measurements in cytometry: light scattering, extinction, absorption, and fluorescence. Methods Cell Biol. 63:2001;107-129.
28. Appay V., Rowland-Jones S.L. The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J. Immunol. Methods. 268:2002;9-19.
29. Whelan J.A., Dunbar P.R., Price D.A., Purbhoo M.A., Lechner F., Ogg G.S., Griffiths G., Phillips R.E., Cerundolo V., Sewell A.K. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163:1999;4342-4348.
30. Skinner P.J., Daniels M.A., Schmidt C.S., Jameson S.C., Haase A.T. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165:2000;613-617.
31. Melan M.A. Overview of cell fixatives and cell membrane permeants. Methods Mol. Biol. 115:1999;45-55.
32. Zell T., Khoruts A., Ingulli E., Bonnevier J.L., Mueller D.L., Jenkins M.K. Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10805-10810.
33. Perez O.D., Nolan G.P. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20:2002;155-162.
34. Tazzari P.L., Cappellini A., Bortul R., Ricci F., Billi A.M., Tabellini G., Conte R., Martelli A.M. Flow cytometric detection of total and serine 473 phosphorylated Akt. J. Cell. Biochem. 86:2002;704-715.
35. Ormerod M.G. Investigating the relationship between the cell cycle and apoptosis using flow cytometry. J. Immunol. Methods. 265:2002;73-80.
36. Fleisher T.A., Dorman S.E., Anderson J.A., Vail M., Brown M.R., Holland S.M. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin. Immunol. 90:1999;425-430.
37. Uzel G., Frucht D.M., Fleisher T.A., Holland S.M. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100:2001;270-276.
38. Juan G., Li X., Darzynkiewicz Z. Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation. Exp. Cell Res. 244:1998;83-92.
39. Juan G., Traganos F., James W.M., Ray J.M., Roberge M., Sauve D.M., Anderson H., Darzynkiewicz Z. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry. 32:1998;71-77.
40. Marodi L., Kaposzta R., Campbell D.E., Polin R.A., Csongor J., Johnston R.B. Jr. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J. Immunol. 153:1994;5643-5649.
41. Zell T., Jenkins M.K. Flow cytometric analysis of T cell receptor signal transduction. Sci. STKE. 2002:2002;PL5.
42. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
43. Constantin C.M., Bonney E.E., Altman J.D., Strickland O.L. Major histocompatibility complex (MHC) tetramer technology: an evaluation. Biol. Res. Nurs. 4:2002;115-127.
44. Blattman J.N., Sourdive D.J., Murali-Krishna K., Ahmed R., Altman J.D. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:2000;6081-6090.
45. Klenerman P., Cerundolo V., Dunbar P.R. Tracking T cells with tetramers: new tales from new tools. Nat. Rev., Immunol. 2:2002;263-272.
46. Dunbar P.R., Ogg G.S. Oligomeric MHC molecules and their homologues: state of the art. J. Immunol. Methods. 268:2002;3-7.
47. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1998;1383-1393.
48. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 8:1998;683-691.
49. Belz G.T., Doherty P.C. Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection. J. Virol. 75:2001;4435-4438.
50. Busch D.H., Pilip I.M., Vijh S., Pamer E.G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:1998;353-362.
51. Masopust D., Vezys V., Marzo A.L., Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2001;2413-2417.
52. Lechner F., Cuero A.L., Kantzanou M., Klenerman P. Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers. Rev. Med. Virol. 11:2001;11-22.
53. Kelleher A.D., Rowland-Jones S.L. Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells. Curr. Opin. Immunol. 12:2000;370-374.
54. Lechner F., Gruener N.H., Urbani S., Uggeri J., Santantonio T., Kammer A.R., Cerny A., Phillips R., Ferrari C., Pape G.R., Klenerman P. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30:2000;2479-2487.
55. Koehne G., Smith K.M., Ferguson T.L., Williams R.Y., Heller G., Pamer E.G., Dupont B., O'Reilly R.J. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 99:2002;1730-1740.
56. Gillespie G.M., Wills M.R., Appay V., O'Callaghan C., Murphy M., Smith N., Sissons P., Rowland-Jones S., Bell J.I., Moss P.A. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 74:2000;8140-8150.
57. Beske O.E., Goldbard S. High-throughput cell analysis using multiplexed array technologies. Drug Discovery Today. 7:2002;S131-S135.
58. Moore K., Rees S. Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screening. 6:2001;69-74.
59. Buchdunger E., Cioffi C.L., Law N., Stover D., Ohno-Jones S., Druker B.J., Lydon N.B. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295:2000;139-145.
60. Buchdunger E., O'Reilly T., Wood J. Pharmacology of imatinib (STI571). Eur. J. Cancer. 38(Suppl. 5):2002;S28-S36.
61. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344:2001;1031-1037.
62. Fjallskog M.L., Lejonklou M.H., Oberg K.E., Eriksson B.K., Janson E.T. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin. Cancer Res. 9:2003;1469-1473.
63. Tashiro E., Maruki H., Minato Y., Doki Y., Weinstein I.B., Imoto M. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. Cancer Res. 63:2003;424-431.
64. Kmet L.M., Cook L.S., Magliocco A.M. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer. 97:2003;389-404.
65. Page C., Lin H.J., Jin Y., Castle V.P., Nunez G., Huang M., Lin J. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res. 20:2000;407-416.
66. Huang P., Oliff A. Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol. 11:2001;343-348.
67. Landberg G., Tan E.M., Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp. Cell Res. 187:1990;111-118.
68. Zamai L., Canonico B., Gritzapis A., Luchetti F., Felici C., Della Felice M., Margomenou L., Papamichail M., Gratama J.W., Papa S. Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocols. J. Biol. Regul. Homeostatic Agents. 16:2002;289-302.
69. Lee G.S., Ryu K.S., Rha J.G., Kim S.P., Namkoong S.E., Han K.T. Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7). J. Obstet. Gynaecol. Res. 28:2002;141-148.
70. Lecoeur H., de Oliveira-Pinto L.M., Gougeon M.L. Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods. 265:2002;81-96.
71. Verdier M., Jayat C., Ratinaud M.H., Troutaud D. Optimization of cell permeabilization for multiparametric flow cytometric analysis with lectin staining. Cytometry. 41:2000;55-61.
72. Lecoeur H., Ledru E., Gougeon M.L. A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes. J. Immunol. Methods. 217:1998;11-26.
73. Kohler C., Orrenius S., Zhivotovsky B. Evaluation of caspase activity in apoptotic cells. J. Immunol. Methods. 265:2002;97-110.
74. Smolewski P., Grabarek J., Halicka H.D., Darzynkiewicz Z. Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis. J. Immunol. Methods. 265:2002;111-121.
75. Bordignon J., Pires Ferreira S.C., Medeiros Caporale G.M., Carrieri M.L., Kotait I., Lima H.C., Zanetti C.R. Flow cytometry assay for intracellular rabies virus detection. J. Virol. Methods. 105:2002;181-186.
76. Mascola J.R., Louder M.K., Winter C., Prabhakara R., De Rosa S.C., Douek D.C., Hill B.J., Gabuzda D., Roederer M. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J. Virol. 76:2002;4810-4821.
77. Ruitenberg J.J., Waters C.A. A rapid flow cytometric method for the detection of intracellular cyclooxygenases in human whole blood monocytes and a COX-2 inducible human cell line. J. Immunol. Methods. 274:2003;93-104.
78. Cao S., Hudnall S.D., Kohen F., Lu L.J. Measurement of estrogen receptors in intact cells by flow cytometry. Cytometry. 41:2000;109-114.